CPC A61K 39/092 (2013.01) [A61K 39/116 (2013.01); A61K 39/145 (2013.01); A61K 39/385 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/22 (2013.01); A61P 31/04 (2018.01); A61K 9/0019 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/70 (2013.01)] | 2 Claims |
1. A method for the prevention of invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP) in patients comprising administering a multivalent immunogenic composition to the patient, wherein the multivalent immunogenic composition comprises S. pneumoniae polysaccharide carrier protein conjugates, wherein each of the conjugates comprises a polysaccharide of a particular S. pneumoniae serotype conjugated to a carrier protein, wherein the S. pneumoniae serotypes consist of 3, 7F, 19A, 22F, 33F, 6A, 15A, 16F, 23A, 23B, 24F, 31, 35B, 8, 9N, 10A, 11A, 12F, de-O-acetylated 15B, 17F, and 20A, and the carrier protein is CRM197.
|